Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C070379 |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Phenylephrine results in increased expression of ATP2A2 protein] | decreases reaction|increases expression | 16236312
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of ATP2A2 mRNA | affects expression | 21346803
|
C050147 |
3-(2,2,2-trimethylhydrazine)propionate |
3-(2,2,2-trimethylhydrazine)propionate results in increased expression of ATP2A2 protein | increases expression | 12439634
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of ATP2A2 mRNA | affects expression | 21346803
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of ATP2A2 mRNA | affects expression | 17562736
|
D000111 |
Acetylcysteine |
Acetylcysteine results in increased expression of ATP2A2 mRNA | increases expression | 16084531
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
D000638 |
Amiodarone |
Amiodarone results in decreased expression of ATP2A2 mRNA | decreases expression | 17535870
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ATP2A2 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in decreased expression of ATP2A2 mRNA | decreases expression | 12558987
|
C006632 |
arsenic trioxide |
arsenic trioxide results in decreased expression of ATP2A2 mRNA | decreases expression | 20458559
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of ATP2A2 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ATP2A2 mRNA | decreases expression | 19150397
|
C070515 |
bisindolylmaleimide I |
bisindolylmaleimide I results in decreased activity of ATP2A2 protein | decreases activity | 17003265
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA | decreases expression | 15336504
|
D002110 |
Caffeine |
ATP2A2 protein affects the susceptibility to Caffeine | affects response to substance | 19328205
|
D002118 |
Calcium |
ATP2A2 protein affects the abundance of Calcium | affects abundance | 19328205
|
D002118 |
Calcium |
ATP2A2 protein alternative form affects the export of Calcium | affects export | 11679415
|
D002118 |
Calcium |
ATP2A2 protein alternative form affects the uptake of Calcium | affects uptake | 11679415
|
D002118 |
Calcium |
PPP3R1 gene mutant form inhibits the reaction [ATP2A2 protein affects the transport of Calcium] | affects transport|decreases reaction | 19700627
|
D002118 |
Calcium |
ATP2A2 protein affects the transport of Calcium | affects transport | 17287366
|
D002118 |
Calcium |
[Phenylephrine results in decreased expression of ATP2A2 protein] which results in decreased transport of Calcium | decreases expression|decreases transport | 19244478
|
D002118 |
Calcium |
[[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein | increases activity|increases expression|increases transport | 16236312
|
D002118 |
Calcium |
[Thapsigargin results in decreased activity of ATP2A2 protein] which results in decreased transport of Calcium | decreases activity|decreases transport | 19244478
|
D002211 |
Capsaicin |
Capsaicin affects the metabolism of ATP2A2 protein | affects metabolic processing | 18037908
|
D002211 |
Capsaicin |
Capsaicin results in decreased expression of ATP2A2 protein modified form | decreases expression | 18037908
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ATP2A2 mRNA | decreases expression | 20106945
|
D019259 |
Lamivudine |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA | affects cotreatment|decreases expression | 11706060
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of ATP2A2 mRNA | increases expression | 18042831
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of ATP2A2 protein | decreases expression | 16244372
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of ATP2A2 protein | decreases expression | 17005195
|
D004317 |
Doxorubicin |
NRG1 protein alternative form inhibits the reaction [Doxorubicin results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate results in increased expression of ATP2A2 mRNA | increases expression | 16084531
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of ATP2A2 mRNA | affects expression | 17555576
|
C054207 |
etomoxir |
etomoxir results in increased expression of ATP2A2 protein | increases expression | 12439634
|
C413355 |
GC 1 compound |
GC 1 compound results in increased expression of ATP2A2 mRNA | increases expression | 11577024
|
C081021 |
Go 6976 |
Go 6976 results in decreased activity of ATP2A2 protein | decreases activity | 17003265
|
D006861 |
Hydrogen Peroxide |
ATP2A2 protein affects the susceptibility to Hydrogen Peroxide | affects response to substance | 19201925
|
D006861 |
Hydrogen Peroxide |
Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of ATP2A2 protein | decreases expression | 17005195
|
D006861 |
Hydrogen Peroxide |
NRG1 protein alternative form inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP2A2 protein] | decreases expression|decreases reaction | 17005195
|
D019469 |
Indinavir |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA | affects cotreatment|decreases expression | 11706060
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of ATP2A2 mRNA | increases expression | 16807920
|
D008094 |
Lithium |
Lithium inhibits the reaction [Methamphetamine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 19149911
|
D008694 |
Methamphetamine |
Lithium inhibits the reaction [Methamphetamine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 19149911
|
D008694 |
Methamphetamine |
Methamphetamine results in decreased expression of ATP2A2 mRNA | decreases expression | 19149911
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of ATP2A2 mRNA | increases expression | 18548127
|
C014707 |
nitrosobenzylmethylamine |
nitrosobenzylmethylamine results in increased expression of ATP2A2 mRNA | increases expression | 17616710
|
D009638 |
Norepinephrine |
ATP2A2 protein affects the abundance of Norepinephrine | affects abundance | 19328205
|
D009638 |
Norepinephrine |
Norepinephrine results in decreased expression of ATP2A2 mRNA | decreases expression | 17592507
|
C025589 |
ochratoxin A |
ochratoxin A results in increased expression of ATP2A2 mRNA | increases expression | 16251485
|
D010126 |
Ozone |
ATP2A2 protein affects the susceptibility to Ozone | affects response to substance | 19201925
|
D017239 |
Paclitaxel |
Paclitaxel results in increased expression of ATP2A2 mRNA | increases expression | 15585946
|
C041786 |
palm oil |
palm oil results in increased expression of ATP2A2 mRNA | increases expression | 18042831
|
D010269 |
Paraquat |
IGF1 gene mutant form inhibits the reaction [Paraquat results in increased expression of ATP2A2 protein] | decreases reaction|increases expression | 17979500
|
D010269 |
Paraquat |
Paraquat results in increased expression of ATP2A2 protein | increases expression | 17979500
|
D010269 |
Paraquat |
Paraquat affects the expression of ATP2A2 mRNA | affects expression | 16854511
|
D010656 |
Phenylephrine |
[Phenylephrine co-treated with ADRA1B protein] results in decreased expression of ATP2A2 protein | affects cotreatment|decreases expression | 11499749
|
D010656 |
Phenylephrine |
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [Phenylephrine results in increased expression of ATP2A2 protein] | decreases reaction|increases expression | 16236312
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased activity of ATP2A2 protein | decreases activity | 17287366
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of ATP2A2 mRNA | decreases expression | 15795322 19244478 17287366 17592507 11577024
|
D010656 |
Phenylephrine |
Phenylephrine results in decreased expression of ATP2A2 protein | decreases expression | 19244478 17287366
|
D010656 |
Phenylephrine |
[Phenylephrine results in decreased expression of ATP2A2 protein] which results in decreased transport of Calcium | decreases expression|decreases transport | 19244478
|
D010656 |
Phenylephrine |
[[Phenylephrine results in increased activity of SLC9A1 protein] which results in increased transport of Calcium] which results in increased expression of ATP2A2 protein | increases activity|increases expression|increases transport | 16236312
|
D010656 |
Phenylephrine |
Phenylephrine results in increased expression of ATP2A2 mRNA | increases expression | 16236312
|
D010656 |
Phenylephrine |
Prazosin inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 17592507 11577024
|
D010656 |
Phenylephrine |
THRB protein affects the reaction [Phenylephrine results in decreased expression of ATP2A2 protein] | affects reaction|decreases expression | 11577024
|
D010656 |
Phenylephrine |
Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 11577024
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ATP2A2 mRNA | increases expression | 18445702 18301758
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 17592507 11577024
|
C035988 |
procymidone |
procymidone results in decreased expression of ATP2A2 mRNA | decreases expression | 15686871
|
D014284 |
Triiodothyronine |
THRB protein promotes the reaction [Triiodothyronine results in increased expression of ATP2A2 mRNA] | increases expression|increases reaction | 11577024
|
D014284 |
Triiodothyronine |
Triiodothyronine inhibits the reaction [Phenylephrine results in decreased expression of ATP2A2 mRNA] | decreases expression|decreases reaction | 11577024
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of ATP2A2 mRNA | increases expression | 11577024
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of ATP2A2 mRNA | affects expression | 17555576
|
C020806 |
tetrabromobisphenol A |
tetrabromobisphenol A results in decreased activity of ATP2A2 protein | decreases activity | 17784851
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATP2A2 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of ATP2A2 mRNA | increases expression | 19465110
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate inhibits the reaction [Thapsigargin results in increased expression of ATP2A2 mRNA] | decreases reaction|increases expression | 19244478
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased expression of ATP2A2 mRNA | decreases expression | 19244478
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in decreased expression of ATP2A2 protein | decreases expression | 19244478
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased activity of ATP2A2 protein | increases activity | 17003265
|
C017953 |
tetramethylpyrazine |
tetramethylpyrazine results in increased expression of ATP2A2 mRNA | increases expression | 15520497
|
D019284 |
Thapsigargin |
ATP2A2 protein affects the susceptibility to Thapsigargin | affects response to substance | 17475205
|
D019284 |
Thapsigargin |
Tetradecanoylphorbol Acetate inhibits the reaction [Thapsigargin results in increased expression of ATP2A2 mRNA] | decreases reaction|increases expression | 19244478
|
D019284 |
Thapsigargin |
Thapsigargin results in decreased activity of ATP2A2 protein | decreases activity | 17287366
|
D019284 |
Thapsigargin |
[Thapsigargin results in decreased activity of ATP2A2 protein] which results in decreased transport of Calcium | decreases activity|decreases transport | 19244478
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of and results in decreased activity of ATP2A2 protein | decreases activity|increases expression | 19244478
|
D019284 |
Thapsigargin |
Thapsigargin results in increased expression of ATP2A2 mRNA | increases expression | 19244478
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of ATP2A2 mRNA | decreases expression | 16054129
|
D014241 |
Trichloroethylene |
Trichloroethylene results in decreased expression of ATP2A2 mRNA | decreases expression | 17905399
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of ATP2A2 mRNA | increases expression | 17127020
|
C025643 |
vinclozolin |
vinclozolin affects the expression of ATP2A2 mRNA | affects expression | 19015723
|
C025643 |
vinclozolin |
vinclozolin results in decreased expression of ATP2A2 mRNA | decreases expression | 15686871
|
D015215 |
Zidovudine |
[Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in decreased expression of ATP2A2 mRNA | affects cotreatment|decreases expression | 11706060
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.96 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
11.11 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Capsaicin |
11.11 | 18926900 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
11.11 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.99 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.36 | 17505938 |
MESH:D000163 |
Acquired Immunodeficiency Syndrome |
|
Zidovudine |
4.26 | 9612607 |
OMIM:101900 |
ACROKERATOSIS VERRUCIFORMIS |
marker/mechanism |
|
| |
MESH:D058186 |
Acute Kidney Injury |
|
Capsaicin |
4.03 | 18460982 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.59 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
8.64 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
8.64 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
8.64 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
8.64 | 14692618 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.30 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.00 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.00 | 16835633 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Paraquat |
3.20 | 11874814 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.00 | 21441931 |
MESH:D000505 |
Alopecia |
|
Capsaicin |
8.04 | 17569567 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
8.04 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
4.16 | 19621015 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.16 | 15513908 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.45 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.26 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.18 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.51 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Amiodarone |
7.48 | 20041841 18218290 18057881 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
7.48 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
8.05 | 15238619 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.05 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
5.95 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
5.95 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
4.09 | 15570426 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
4.09 | 16292516 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
6.79 | 16516891 |
MESH:D001249 |
Asthma |
|
Ozone |
6.79 | 16373670 17854713 |
MESH:D001249 |
Asthma |
|
Tretinoin |
6.79 | 16456186 |
MESH:D001281 |
Atrial Fibrillation |
|
Amiodarone |
3.46 | 18651412 19698954 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.36 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
2.36 | 8570775 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
4.51 | 19761891 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
3.85 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
4.00 | 20338123 17594078 20046352 19153942 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Amiodarone |
23.36 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
23.36 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
23.36 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
23.36 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
23.36 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.21 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.38 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.11 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.04 | 15867366 |
MESH:D001919 |
Bradycardia |
|
Capsaicin |
9.00 | 18207255 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
9.00 | 15306635 |
MESH:D002545 |
Brain Ischemia |
|
Capsaicin |
4.40 | 19211983 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.31 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
5.05 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
5.05 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
5.05 | 11325840 15994142 17426702 18382427 16115903 15634643 18234424 16935488 15668708 15939500 15567936 15136595 16322301 15993339 19526202 16595493 17369602 16826403 17983394 15692762 16264153 16096432 18695136 18628466 |
MESH:D001943 |
Breast Neoplasms |
|
ochratoxin A |
5.05 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
5.05 | 16244791 18234424 16273361 18223236 16115903 18323546 15136595 11325840 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
5.05 | 19200415 21138602 19289846 17049068 19288272 19410462 20859285 18855134 18425577 19189210 16273361 19115204 19059307 15668708 19103187 19011961 19244106 17893378 20390343 17440819 17261762 19487384 21152245 15565566 18984771 19221464 18997820 18351453 19066611 18815881 20005174 16873071 20135344 19189212 17242785 20544844 19155303 19084267 18629630 19142967 20065188 11161223 16202921 18821012 16818667 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
5.05 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
5.05 | 16443354 16873071 16166294 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
5.05 | 15986119 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.22 | 19059883 18417511 16777450 15516495 18315731 17626835 14754758 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.01 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.80 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.17 | 16183385 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.22 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.34 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.94 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.57 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
12.15 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
12.15 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
12.15 | 15073043 16217749 11135700 15553829 14691202 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
12.15 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
12.15 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
12.15 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
12.15 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.29 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
2.86 | 1485588 16201981 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.61 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
12.14 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
12.14 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
12.14 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
12.14 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
12.14 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.11 | 17572228 |
MESH:D006332 |
Cardiomegaly |
marker/mechanism |
|
| 11679415 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
9.61 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
9.61 | 11754973 17124262 11179087 16170337 17287366 15728586 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
9.61 | 18670907 16120746 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.14 | 15811867 17351982 16278810 15505089 16952015 16269455 15792986 16731534 17007740 17519947 17974986 17382496 16612575 17924179 17928571 16651473 16242529 16109756 16364871 15476868 17131338 18627295 17329180 17308081 16455267 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Amiodarone |
5.20 | 19225199 15710769 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
5.20 | 16243910 17334414 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
3.11 | 16936243 |
MESH:D002341 |
Carotid Artery Thrombosis |
|
Amiodarone |
4.51 | 18974383 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
4.96 | 8216760 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
10.27 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
10.27 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
10.27 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
12.68 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.68 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
12.68 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.68 | 12371664 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.01 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.67 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
10.82 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
10.82 | 16919318 17333356 16105132 11677210 17681005 15861022 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
10.82 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.57 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
4.85 | 15668235 8697196 12621046 15340226 16354765 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
4.85 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.15 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
3.15 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.15 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.15 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
7.57 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
7.57 | 17141729 14669216 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.64 | 12609071 |
MESH:D003371 |
Cough |
|
Capsaicin |
4.59 | 10350223 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.75 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
ochratoxin A |
4.75 | 20036863 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
4.75 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.75 | 9224671 17551590 14991402 10589399 9125849 16925845 8800419 9211117 9142499 9664655 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
3.79 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.46 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.88 | 19747007 |
MESH:D007644 |
Darier Disease |
marker/mechanism |
|
| 16733453 20338123 |
MESH:D007644 |
Darier Disease |
|
Lithium |
5.34 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.56 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.80 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.13 | 18249437 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.18 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
4.03 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.03 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
2.99 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
21.70 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
21.70 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
21.70 | 10774834 11461765 10663392 19739265 19164858 11287661 14550746 16081117 12540782 18071297 16393943 19416960 12153990 19085960 19923254 18713872 2444490 12705907 16485898 16177239 11529661 10915739 19370779 17906064 17562736 15968718 12594235 14725611 11834606 16781746 14986274 11739529 12958197 11743745 11421492 16109766 15619225 17522070 16227642 12392966 19420014 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
21.70 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Amiodarone |
21.70 | 18218290 15265979 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
21.70 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
21.70 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
21.70 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
21.70 | 7120509 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.51 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
16.09 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
16.09 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
16.09 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zidovudine |
16.09 | 15040536 |
MESH:D004381 |
Duodenal Ulcer |
|
Capsaicin |
4.15 | 10671773 11535926 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.03 | 18367378 |
MESH:D004487 |
Edema |
|
bisindolylmaleimide I |
12.34 | 8273558 |
MESH:D004487 |
Edema |
|
pirinixic acid |
12.34 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
12.34 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
12.34 | 9599246 16716910 7812673 8273558 11698051 15177302 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
10.00 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
10.00 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
7.14 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
7.14 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
10.20 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
10.20 | 16202921 19155303 20544844 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
10.20 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.52 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.57 | 18037988 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
3.98 | 821787 |
MESH:D004935 |
Esophageal Diseases |
|
Capsaicin |
5.13 | 19566590 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.82 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
11.82 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
11.82 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
nitrosobenzylmethylamine |
11.82 | 16805852 15150132 15878914 15547721 15547733 15623463 15264214 16704527 16510608 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
11.82 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
7.38 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
7.38 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Amiodarone |
34.32 | 14986274 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
34.32 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
34.32 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
34.32 | 17967931 19004024 19551842 18296743 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
34.32 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
34.32 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
34.32 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Zidovudine |
34.32 | 18299183 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
2.86 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.90 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.95 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.53 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.53 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
16.56 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
16.56 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.56 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
16.56 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
3.71 | 16904648 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.09 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.36 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.71 | 16417039 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.64 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Capsaicin |
9.77 | 18405923 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
9.77 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
9.77 | 17312396 |
MESH:D005911 |
Gliosis |
|
Paraquat |
4.58 | 11124998 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.01 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
6.50 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
6.50 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.57 | 16084493 |
MESH:D006356 |
Heartburn |
|
Capsaicin |
5.13 | 19566590 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
13.29 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
13.29 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
13.29 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
13.29 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
marker/mechanism |
|
| 19328205 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.08 | 16244371 12587719 14766674 16330681 18674790 17888722 16879835 16707910 16495754 16144979 17875725 18006777 16244372 |
MESH:D006333 |
Heart Failure |
|
3-(2,2,2-trimethylhydrazine)propionate |
14.04 | 12439634 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
14.04 | 17481944 |
MESH:D006333 |
Heart Failure |
|
etomoxir |
14.04 | 12439634 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
14.04 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.39 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Zidovudine |
4.18 | 12579204 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
3.85 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.82 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
4.44 | 11394713 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.58 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.58 | 15274664 15631357 12044531 16476009 15309715 |
MESH:D006529 |
Hepatomegaly |
|
Amiodarone |
11.19 | 15265979 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
11.19 | 18467677 16221962 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
11.19 | 15340226 12621046 16120746 |
MESH:D015658 |
HIV Infections |
|
Indinavir |
9.19 | 15388451 11363243 11141242 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
9.19 | 17530837 11141242 9296927 20032539 |
MESH:D015658 |
HIV Infections |
|
Zidovudine |
9.19 | 20032539 11141242 11698656 17358032 11363243 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
2.94 | 15147373 18501091 17606976 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.46 | 15340226 16959395 8697196 16354765 18606429 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
15.00 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Capsaicin |
15.00 | 17434803 17043245 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
15.00 | 12727271 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
15.00 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Amiodarone |
7.46 | 8137927 9751232 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
7.46 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.01 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.68 | 20558911 |
MESH:D006948 |
Hyperkinesis |
|
Methamphetamine |
4.93 | 17658665 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.09 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.12 | 10903974 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
7.12 | 12717712 8949925 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.12 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.04 | 12791704 18502941 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.25 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.47 | 6740701 |
MESH:D007037 |
Hypothyroidism |
|
Amiodarone |
3.95 | 17991464 18020914 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.93 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
8.92 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
Paraquat |
8.92 | 4850670 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
8.92 | 16467254 |
MESH:D007249 |
Inflammation |
|
bisindolylmaleimide I |
15.71 | 8273558 |
MESH:D007249 |
Inflammation |
|
Capsaicin |
15.71 | 16956363 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
15.71 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
15.71 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
15.71 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
15.71 | 8273558 7812673 15177302 11698051 7562506 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
5.94 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
5.94 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.21 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
8.22 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
8.22 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
3.85 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
tetramethylpyrazine |
6.13 | 18842672 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
11.57 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
11.57 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
11.57 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
ochratoxin A |
11.57 | 11409539 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.41 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.41 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
18.39 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
18.39 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
ochratoxin A |
18.39 | 16251485 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
18.39 | 18625569 |
MESH:D007680 |
Kidney Neoplasms |
|
Zidovudine |
18.39 | 12579204 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
4.46 | 16316344 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
5.29 | 15070760 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.29 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.57 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
8.13 | 12560223 17077332 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Zidovudine |
8.13 | 20370541 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.73 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.99 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
7.76 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
7.76 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.43 | 16467208 17050201 16968895 20471514 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.43 | 19850784 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
6.32 | 11161223 17649720 15748426 12679006 16331271 17712046 16966277 15622746 19225113 15213294 17217047 16823087 15336539 19075265 12018890 17869043 12712474 16891316 19035177 11468182 19642359 9834237 16112521 17107899 16330433 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
6.32 | 19029980 9834237 16788101 17107899 17301526 17339181 19075265 17712046 19642359 17217047 16891316 17506722 17361223 12679006 17649720 16140955 16935935 16331271 19035177 15748426 17294898 17368321 19225113 16766008 16823087 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.81 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.16 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
2.88 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Amiodarone |
6.50 | 15342952 17567588 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
6.50 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.29 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.54 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
7.46 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
7.46 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
7.46 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
7.46 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
7.46 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.46 | 16248980 18397230 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.73 | 16611625 12969438 19460945 11587558 16610002 12587719 19784758 19014921 |
MESH:D008107 |
Liver Diseases |
|
Capsaicin |
3.73 | 16956363 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.73 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
14.64 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
14.64 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.64 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.64 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.64 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.64 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.64 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.64 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.64 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.64 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
14.64 | 7955063 |
MESH:D008133 |
Long QT Syndrome |
|
Amiodarone |
6.71 | 17391786 15350150 11989578 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
6.71 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
10.17 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Amiodarone |
10.17 | 12587719 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
10.17 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Amiodarone |
3.89 | 18516814 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.30 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
11.25 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
11.25 | 20064080 20464547 20869020 18569708 17053015 20135361 18520028 18816296 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
11.25 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
11.25 | 7614698 8597069 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
11.25 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
11.25 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
11.25 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Zidovudine |
11.25 | 18800350 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.04 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
7.39 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
7.39 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.01 | 15621674 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.19 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
11.19 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
ochratoxin A |
11.19 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
11.19 | 16827153 19196722 19196723 11731420 14580682 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
11.19 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
3.96 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.53 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
8.35 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
8.35 | 17992120 11746506 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
8.35 | 12025231 16342250 12040289 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
8.35 | 19393235 12393984 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
8.35 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.61 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.01 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
3.86 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
2.80 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.20 | 16801185 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.52 | 10496685 |
MESH:D048629 |
Micronuclei, Chromosome-Defective |
|
Zidovudine |
5.25 | 17358032 |
MESH:D008850 |
Microphthalmos |
|
ochratoxin A |
5.25 | 20036863 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.98 | 15792986 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
4.94 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.74 | 16381670 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.22 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
9.87 | 11468182 19417148 19549372 15949261 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
Capsaicin |
9.87 | 17505005 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
9.87 | 14749477 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
4.92 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
2.95 | 16239165 |
MESH:D009164 |
Mycobacterium Infections |
|
Indinavir |
4.83 | 21442799 |
MESH:D009181 |
Mycoses |
|
Amiodarone |
4.32 | 17974566 12754197 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.09 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
6.21 | 16882451 16105982 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.21 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
8.03 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
8.03 | 16288908 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
8.03 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.56 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
marker/mechanism |
|
| 10734148 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
7.33 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.33 | 16411023 |
MESH:D017682 |
Myocardial Stunning |
marker/mechanism |
|
| 16317512 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.29 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.42 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
11.47 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
11.47 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
11.47 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
11.47 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.30 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
9.29 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
9.29 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
9.29 | 16594593 16946489 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
9.29 | 11911487 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.42 | 19200415 19196722 19189210 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.21 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
3.85 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
7.67 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.67 | 16889571 15640375 |
MESH:D009410 |
Nerve Degeneration |
|
Paraquat |
3.27 | 16893418 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
7.70 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
7.70 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
14.21 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
14.21 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
ochratoxin A |
14.21 | 20036863 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
14.21 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
2.94 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.40 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Capsaicin |
4.56 | 17961222 |
MESH:D009765 |
Obesity |
|
Capsaicin |
6.46 | 19056576 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
6.46 | 21332399 11836018 20518802 17217161 18674790 20132043 18457598 16723640 19632207 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
6.46 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.47 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
7.47 | 14694615 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.41 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.41 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.65 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
6.69 | 16624393 12452020 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
6.69 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
6.69 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
8.65 | 16870215 |
MESH:D010146 |
Pain |
|
Capsaicin |
8.65 | 16996476 19081190 17434803 18987195 17043245 17084039 |
MESH:D010146 |
Pain |
|
Tretinoin |
8.65 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
7.28 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
7.28 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
7.28 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.16 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
7.76 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
7.76 | 18922899 8330346 12065085 18404319 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.63 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Paraquat |
2.58 | 15451049 15824117 12911755 16140633 11445065 16510128 11181820 11124998 |
MESH:D010302 |
Parkinson Disease, Secondary |
|
Paraquat |
3.87 | 16190885 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.66 | 12520081 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.57 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.57 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
4.57 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Ozone |
9.16 | 18007984 18381685 18929643 |
MESH:D011014 |
Pneumonia |
|
Paraquat |
9.16 | 12504350 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.01 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.74 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
7.59 | 11118676 11222880 11399792 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
7.59 | 18042343 18220299 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.36 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.87 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.87 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.87 | 15749863 15897917 16888761 16868541 16729912 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
1.87 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.87 | 16356831 16729912 17136230 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.87 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.36 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.08 | 16636307 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.74 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.00 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.22 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Amiodarone |
4.99 | 11597910 12490602 12832656 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Paraquat |
4.99 | 17997886 16324872 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
3.66 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
Capsaicin |
5.78 | 18460982 19211983 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
5.78 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
7.69 | 12210543 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Paraquat |
7.69 | 11700416 |
MESH:D012135 |
Respiratory Sounds |
|
Paraquat |
3.50 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.29 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Paraquat |
3.43 | 16458197 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
4.96 | 9296927 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.57 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.49 | 15625365 18313854 15675481 17710206 17203757 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
8.47 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
8.47 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.22 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.07 | 18551238 |
MESH:D012640 |
Seizures |
|
Lithium |
5.07 | 19660546 |
OMIM:609620 |
SHORT QT SYNDROME 1 |
|
Amiodarone |
4.51 | 18724381 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.13 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.55 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
22.55 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
22.55 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
22.55 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.55 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
22.55 | 8330346 11807781 18404319 12065085 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
22.55 | 16467112 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
4.74 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
4.52 | 17225163 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.01 | 15625365 17203757 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
9.61 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
9.61 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.47 | 19457130 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
5.20 | 19430551 19570321 19951488 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
7.24 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
7.24 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
nitrosobenzylmethylamine |
7.24 | 12958204 17575124 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
7.24 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
7.24 | 17261132 |
MESH:D013274 |
Stomach Neoplasms |
|
Zidovudine |
7.24 | 17696246 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
5.98 | 17918041 |
MESH:D013276 |
Stomach Ulcer |
|
Amiodarone |
5.98 | 18087811 |
MESH:D013610 |
Tachycardia |
|
Amiodarone |
9.30 | 11238279 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
9.30 | 3261545 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Amiodarone |
3.65 | 19225199 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.24 | 16930453 |
MESH:D013705 |
Temporomandibular Joint Disorders |
|
Capsaicin |
5.14 | 17997062 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.09 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.67 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Amiodarone |
10.10 | 19731979 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
10.10 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
9.46 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
9.46 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
9.46 | 16026305 17045167 |
MESH:D013971 |
Thyrotoxicosis |
|
Amiodarone |
4.30 | 19584973 18020914 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.29 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
Amiodarone |
8.36 | 17467628 11989578 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
8.36 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
2.85 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
13.00 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
13.00 | 12973940 11780464 12845720 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
13.00 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
13.00 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
13.00 | 16712894 8653321 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
3.74 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.45 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.18 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
2.76 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.02 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.40 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Zidovudine |
4.20 | 12579204 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.01 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.02 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
3.66 | 16364871 17334414 17638931 17678736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.51 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.66 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.25 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.48 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
3.85 | 17120751 |